List view / Grid view
27 May 2016 | By Victoria White, Digital Content Producer
Scientists are able to identify patients with stomach cancer who are most likely to respond to AZD4547 by measuring copies of the FGFR2 gene in the bloodstream...
31 March 2016 | By Victoria White
Children with cancer will be offered testing for genetic mutations in their tumours as part of an initiative to personalise children’s cancer treatment...
21 March 2016 | By Victoria White
Professor Paul Workman of The Institute of Cancer Research, which discovered abiraterone, said the recommendation was “a big victory for men"...
11 March 2016 | By Victoria White
A trial has shown that lapatinib plus trastuzumab before surgery shrinks and may even destroy tumours in women with HER2+ breast cancer within 11 days. The EPHOS B trial studied 257 women with HER2 positive breast cancer in the short gap between initial diagnosis and surgery to remove their tumours.…
3 March 2016 | By Victoria White
In a study, some 67% of 347 women given palbociclib plus fulvestrant showed clinical benefit compared with 40% of 174 women given placebo plus fulvestrant...
16 February 2016 | By Victoria White
Scientists have developed a test called the Ecosystem Diversity Index which combines methods used by ecologists with a powerful cancer imaging technique...
22 January 2016 | By Victoria White
NICE recommends that nivolumab is made available on the NHS as a treatment option for patients with advanced (unresectable or metastatic) melanoma...
18 December 2015 | By Victoria White
The European Commission has approved the use of Amgen’s Imlygic (talimogen laherparepvec) for the treatment of adults with unresectable melanoma...
10 December 2015 | By Victoria White
Teams at The University of Manchester and The Institute of Cancer Research, London, have described detailed development of oxygen-enhanced magnetic resonance imaging (MRI) technology to map areas of oxygen deprivation within tumours.
29 October 2015 | By Victoria White
The trial is a milestone in cancer treatment as the first to show the benefits of ‘precision medicine’ in prostate cancer...
27 October 2015 | By Victoria White
A new study of more than 25,000 men has uncovered four new genetic variants associated with increased risk of testicular cancer...
23 October 2015 | By Victoria White
If approved by the European Commission, Imlygic would be the first in a class of novel agents known as oncolytic immunotherapies...
21 October 2015 | By Victoria White
Research has found that women whose breast cancer had begun to spread and who tested positive in the αB-crystallin test were three times more likely to have disease that spread to the brain...
15 October 2015 | By Victoria White
In a study, examining the activity of only five genes in a sample of the tumour was enough to identify high-risk children who might benefit from more intensive treatment...
13 October 2015 | By Victoria White
Researchers have shown the bowel cancer can be assigned into different "consensus molecular subtypes"...
